OncoCyte
(NASDAQ:OCX)
$0.4988
0.0236[4.97%]
At close: Dec 2(Delayed 15-Minutes)
Get Real Time Here
$0.4877
-0.0111[-2.23%]
After Hours: 4:43PM EDT
Day Range0.45 - 0.552 Wk Range0.35 - 2.68Open / Close0.48 / 0.5Float / Outstanding78.7M / 118.6M
Vol / Avg.626.3K / 314.5KMkt Cap59.2MP/E-50d Avg. Price0.65
Div / Yield-Payout Ratio-Total Float78.7MEPS-0.08

OncoCyte Stock (NASDAQ:OCX), Quotes and News Summary

OncoCyte Stock (NASDAQ: OCX) stock price, news, charts, stock research, profile.

Loading...
Day Range0.45 - 0.552 Wk Range0.35 - 2.68Open / Close0.48 / 0.5Float / Outstanding78.7M / 118.6M
Vol / Avg.626.3K / 314.5KMkt Cap59.2MP/E-50d Avg. Price0.65
Div / Yield-Payout Ratio-Total Float78.7MEPS-0.08
Globe Newswire - Nov 10, 2022, 4:30PM
Globe Newswire - Aug 30, 2022, 4:27PM
Globe Newswire - Aug 10, 2022, 4:05PM
Globe Newswire - May 11, 2022, 4:05PM
Seeking Alpha - Nov 19, 2022, 11:10PM
Seeking Alpha - Nov 15, 2022, 11:16AM
TipRanks - Nov 13, 2022, 11:05PM
TipRanks - Nov 11, 2022, 5:35AM
Seeking Alpha - Oct 18, 2022, 12:41PM
InvestorsObserver - Sep 7, 2022, 10:36AM
InvestorsObserver - Aug 30, 2022, 1:58PM
InvestorsObserver - Apr 19, 2022, 9:47AM
TalkMarkets - Apr 19, 2022, 8:18AM
InvestorsObserver - Apr 14, 2022, 6:49AM
InvestorsObserver - Apr 11, 2022, 3:49PM
Sector: Health Care.Industry: Biotechnology
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States, and it earns revenue from the sale of diagnostic tests.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.110-0.080 0.0300
REV1.480M1.017M-463.000K
Q2 2022Est.ActualSurprise
EPS-0.110-0.100 0.0100
REV2.700M2.067M-633.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy OncoCyte (OCX) stock?

A

You can purchase shares of OncoCyte (NASDAQ: OCX) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for OncoCyte (OCX) stock?

A

The latest price target for OncoCyte (NASDAQ: OCX) was reported by Lake Street on Thursday, December 1, 2022. The analyst firm set a price target for 0.50 expecting OCX to rise to within 12 months (a possible 0.24% upside). 16 analyst firms have reported ratings in the last year.

Q

Current Stock Price for OncoCyte (OCX)?

A

The stock price for OncoCyte (NASDAQ: OCX) is $0.4988 last updated December 2, 2022, 9:00 PM UTC.

Q

Does OncoCyte (OCX) pay a dividend?

A

There are no upcoming dividends for OncoCyte.

Q

When is OncoCyte (NASDAQ:OCX) reporting earnings?

A

OncoCyte’s Q3 earnings are confirmed for Thursday, November 10, 2022.

Q

Is OncoCyte (OCX) going to split?

A

There is no upcoming split for OncoCyte.

Q

What sector and industry does OncoCyte (OCX) operate in?

A

OncoCyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.